Hana Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2017	FY 2016
Period Ending	Feb '26 Feb 19, 2026	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Debt / Equity Ratio	0.36	0.36	0.56
Debt / EBITDA Ratio	0.82	0.82	1.13
Debt / FCF Ratio	1.91	1.91	7.45
Net Debt / Equity Ratio	0.15	0.15	0.50
Net Debt / EBITDA Ratio	0.36	0.36	1.02
Net Debt / FCF Ratio	0.83	0.83	6.69
Asset Turnover	1.09	1.09	-
Inventory Turnover	2.43	2.43	-
Quick Ratio	1.22	1.22	1.23
Current Ratio	1.63	1.63	1.77
Return on Equity (ROE)	35.53%	35.53%	-
Return on Assets (ROA)	15.52%	15.52%	-
Return on Invested Capital (ROIC)	28.20%	28.20%	22.58%
Return on Capital Employed (ROCE)	34.30%	34.30%	29.40%
Payout Ratio	4.21%	4.21%	-
Buyback Yield / Dilution	-	-39.75%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.